XML 33 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Inventory
 12 Months Ended
Dec. 31, 2015
Inventory Disclosure [Abstract]  
Inventory

12. Inventory

Inventory consists of the following as of December 31, 2015:

 

(in thousands)    December 31, 2015  

Raw materials

    $ 900   

Work in process

      2,743   

Finished goods

      74   
  

 

 

  

Total inventory

    $ 3,717   

Inventory acquired prior to receipt of marketing approval of ONIVYDE was expensed as research and development expense as incurred. The Company began to capitalize the costs associated with the production of ONIVYDE upon receipt of FDA approval on October 22, 2015.